5UB-26131-54963
3 vaccinations
3 coded responses
24 check-ins
3 free-text entries
2 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 015 / MA
- Registered
- 2021-01-17
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-22
Dose 1 — Pfizer-BioNTech
-
2021-01-15
Dose 2 — Pfizer-BioNTech
-
2021-01-17
Registered in v-safe
-
2021-01-17
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Headache, Fatigue or tiredness, Nausea · Be unable to do your normal daily activitiesAdult check-in
-
2021-01-17
Report sent to call center — days 1–6 daily, dose 2Be unable to do your normal daily activities1 call case(s)
-
2021-01-19
Survey response — days 1–6 daily, dose 2MedDRA: Lymphadenopathy — Feeling: Fair · Site: PainFree text: Swollen axillary lymph nodesMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-01-24
- 2021-02-07
- 2021-02-12
- 2021-02-19
- 2021-02-26
- 2021-04-16
- 2021-07-16
-
2021-10-02
Dose 3 — Pfizer-BioNTech
-
2021-10-03
Health check-in — days 1–6 daily, dose 3Feeling: Poor · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activitiesAdult check-in
-
2021-10-04
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Headache, Fatigue or tiredness, NauseaAdult check-in
-
2021-10-05
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Headache, Fatigue or tiredness, NauseaAdult check-in
- 2021-10-06
- 2021-10-07
- 2021-10-08
- 2021-10-09
- 2021-10-16
- 2021-10-23
- 2021-10-30
- 2021-11-08
- 2021-11-13
- 2022-01-01
-
2022-04-02
Survey response — 6 months, dose 3MedDRA: Pregnancy — Feeling: Good · Be unable to do your normal daily activitiesFree text: Pregnancy, morning sicknessMedDRA releases: 2024-11 · check-in free text available
-
2022-10-02
Survey response — 12 months, dose 3MedDRA: Abortion spontaneous, Pregnancy — Feeling: Good · Get care from a doctor or other healthcare professional · Emergency room or emergency department visitFree text: Pregnancy starting in March 2022. Miscarried at 12 weeks on May 9th. I am currently 12 weeks pregnant again.MedDRA releases: 2024-11 · check-in free text available
-
2022-10-02
Report sent to call center — 12 months, dose 3Get care from a doctor or other healthcare professionalEmergency room or emergency department visit · 1 call case(s)
- 2022-10-03
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-22 | Pfizer-BioNTech | |
| 2 | 2021-01-15 | Pfizer-BioNTech | |
| 3 | 2021-10-02 | Pfizer-BioNTech | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-01-17 | priority 2/3 | |
| 2022-10-02 | Unsuccessful |
Free text
Release 2 — days 1–6 daily, dose 2
Systemic reaction (other): Swollen axillary lymph nodes
Release 11 — 6 months, dose 3
Symptoms: Pregnancy, morning sickness
Release 12 — 12 months, dose 3
Symptoms: Pregnancy starting in March 2022. Miscarried at 12 weeks on May 9th. I am currently 12 weeks pregnant again.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Abortion spontaneous | · | · | ✓ |
| SD | Pregnancy | · | · | ✓ |
| SRO | Lymphadenopathy | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release